Candriam Luxembourg S.C.A. »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 1.4k 975.89
2023-12-31 $3.7M 4.0k 934.75